Myopia (nearsightedness) is usually described in optical terms, but the tissue story underneath it shouldn’t be ignored. As the eye elongates in myopia, the sclera is part of what changes with it. That has pushed more attention toward scleral cross-linking as a way to mechanically reinforce the back of the eye rather than only correcting myopic vision after the fact.
A recent study out of Taiyuan University of Technology published in Translational Vision Science & Technology looked at that question in young rabbits using an oxygen-supplemented accelerated protocol. The authors compared it with a more traditional scleral cross-linking approach and followed the animals over three months to see what changed in refraction, axial length, tissue stiffness, and ocular safety. Mechanical testing was a central part of that story, and that is where the CellScale BioTester came in. By testing scleral strips in saline under controlled loading, the group could check whether the treated tissue was actually stiffer after surgery, not just whether the eye looked different afterward.
In practice, that is what makes this paper interesting.
The question isn’t simply “can we shorten the protocol.” It’s whether an accelerated scleral cross-linking protocol still leaves a clear mechanical fingerprint in the tissue, and whether the short-term safety checks look reasonable at the same time.
Diagram of the treated scleral region and the tissue sampling location used for tensile testing. The highlighted treatment area shows where cross-linking was applied, while the adjacent strip indicates where specimens were collected later for mechanical analysis. Adapted from Ben Hilal, H, et al. Trans Vis Sci Tech. 2026.
Why scleral cross-linking is being explored for myopia
The basic idea behind scleral cross-linking is fairly direct. If the sclera can be made mechanically more resistant to stretch, that may help limit axial elongation, which is a major feature of progressive myopia. The treatment concept is related in spirit to other ocular stiffening approaches, although the tissue target and clinical question are different. We have covered related ophthalmic work before in our research highlights on corneal crosslinking optimization and corneal stiffening, where tissue reinforcement is also part of the mechanical discussion.
What this study adds is a closer look at whether an oxygen-supported accelerated protocol can keep up with a conventional one. The authors treated the superonasal sclera of rabbit eyes using riboflavin and UVA exposure. One group received the accelerated oxygen-supplemented protocol, while another received a traditional protocol with lower irradiance and longer exposure. The untreated contralateral eyes served as controls.
That setup gave them a way to ask a few linked questions at once. Did refraction hold up better after treatment? Did axial elongation slow? And did the tissue itself become mechanically stiffer in a way that could plausibly matter?
How accelerated scleral cross-linking was tested in vivo
The surgery workflow was fairly structured. Riboflavin was applied to the exposed scleral region, followed by UVA irradiation under either high-oxygen or normoxic conditions depending on the group. The accelerated condition used higher irradiance for a much shorter duration, which is really the practical reason this approach draws interest in the first place. If accelerated scleral cross-linking can preserve the mechanical effect of the traditional method, it becomes easier to imagine why groups would keep working on it.
The follow-up was not limited to one type of measurement. The authors tracked spherical equivalent refraction and axial length over time, then paired those in vivo measurements with ex vivo biomechanical testing and safety assessments. Electroretinography and histology were used to look for signs of retinal or posterior tissue damage.
The CellScale BioTester used in this research for tensile testing of excised scleral strips after surgery. Adapted from Ben Hilal, H, et al. Trans Vis Sci Tech. 2026.
One thing that stands out here is that the paper does not leave the mechanics as an assumption. The authors did not simply infer tissue reinforcement from ocular measurements alone. They removed scleral strips from the treated region and tested them directly, which gives the myopia scleral biomechanics side of the paper more weight.
What BioTester tensile testing showed about scleral stiffening
The group used a BioTester 5000 benchtop mechanical testing system to perform tensile testing on scleral strips harvested at one and three months after treatment. Samples were mounted in clamps, submerged in saline, preconditioned, and then pulled under quasistatic loading so the authors could generate stress-strain curves and calculate tangent modulus.
For readers less familiar with that workflow, our overview of tensile testing in biomaterials gives a useful starting point for how hydrated soft tissues are typically loaded and analyzed.
In this study, those BioTester measurements appear to be the clearest evidence that scleral cross-linking changed the tissue mechanically. Both the accelerated oxygen-supplemented group and the traditional group showed increased tangent modulus relative to their controls. The stiffening remained visible at one month and again at three months. The fold-change comparison between the two protocols did not suggest a major loss of effect with the accelerated approach, which is really the most practical comparison in the paper.
Biomechanical results from scleral strip testing. In panels A and B, stress-strain curves show separation between treated and control tissue at one and three months. Panel C shows higher tangent modulus in both cross-linking groups relative to controls. Panel D compares fold-change in tangent modulus between the accelerated oxygen-supplemented and traditional protocols. Adapted from Ben Hilal, H, et al. Trans Vis Sci Tech. 2026.
That is probably the central result from a CellScale perspective. The paper is not only saying that oxygen-supplemented scleral cross-linking may help slow axial elongation. It is showing that the treated sclera behaved differently when mechanically loaded afterward. That sort of direct measurement matters because the treatment goal is ultimately mechanical, even if the clinical motivation is refractive.
Linking biomechanics to axial elongation in scleral cross-linking
The ocular outcome data help round out the story. Across the three-month window, the treated eyes tended to hold refraction better and showed less axial elongation than the paired controls. The accelerated oxygen-supplemented protocol tracked closely with the traditional protocol at the same follow-up points. That’s why the authors treat the faster approach as a workable option, not just a time-saving shortcut.
In vivo ocular measurements after treatment. Panel A shows spherical equivalent refraction over time, while panel B shows axial length. Across follow-up, treated eyes generally maintained refraction better and showed less axial elongation than their corresponding controls. Adapted from Ben Hilal, H, et al. Trans Vis Sci Tech. 2026.
There is a useful balance here between the biology and the mechanics. The refraction and axial length data tell you something happened at the whole-eye level. The tensile data suggest the sclera itself became stiffer. It would be too neat to claim that one fully explains the other from this study alone, especially in a rabbit model over a limited follow-up window, but the two sets of measurements do move in the same direction.
How the BioTester was used in this research
After euthanasia at the designated follow-up time points, the authors excised scleral strips from the treated superonasal equatorial region and the matching region in the contralateral control eyes. Those strips were mounted in the BioTester with toothed clamps and tested in saline to preserve a hydrated environment during loading. The system recorded force and displacement, which were then converted into stress-strain data for modulus calculation.
Close-up of the scleral strip mounted in the BioTester grips before uniaxial loading. The image shows how the small tissue sample was secured for mechanical testing after excision. Adapted from Ben Hilal, H, et al. Trans Vis Sci Tech. 2026.
That matters because tissue mechanics in the eye are small-scale and not especially forgiving. The strip geometry is limited, the tissue is soft, and hydration conditions can affect response. In that sense, the BioTester sclera tensile testing workflow is not a background detail. It is the part of the paper that turns the treatment question into a measurable materials problem.
Safety findings after scleral cross-linking over 3 months
The safety side of the paper is also worth mentioning, even though it is not the main focus of this highlight. Electroretinography and histological assessment did not show obvious short-term retinal functional impairment or posterior tissue injury in the treated groups over the three-month period. That does not settle the broader translational question, and the paper is still working with a young rabbit model and a fairly modest follow-up period, but it does remove some of the immediate concern that faster irradiation under oxygen support would necessarily come with obvious damage.
That is part of why this study feels useful rather than merely promising. It looked at scleral cross-linking from more than one angle. Not every paper does that. Here, stiffness, axial elongation, refraction, and safety were all measured in the same framework, which makes the results easier to interpret as a whole.
Citation
About the BioTester
The BioTester is CellScale’s platform for biaxial mechanical testing of soft tissues, biomaterials, and engineered specimens under controlled loading conditions. In studies like this one, it is used to generate force-displacement data from delicate samples that can then be converted into stress-strain behaviour and modulus values. That makes it useful in areas such as ophthalmic biomechanics and corneal tissue engineering as well as broader soft tissue and biomaterials research.
In this rabbit study, the BioTester was used to test whether scleral cross-linking actually changed tissue stiffness after treatment. That is a small point to state plainly, but it is really the center of the paper. The authors were not only trying to speed up a protocol. They were trying to show that faster treatment still produced a mechanical effect worth measuring.
There is still more to work out around long-term response, translation, and how these protocols may behave in other models. Even so, this study gives a fairly concrete example of how accelerated scleral cross-linking can be evaluated with direct tensile measurements rather than indirect assumptions alone.
